(Q51590530)

7 April 2018

title

Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects. (English)

1 reference

7 April 2018

author

Jens Juul Holst

3

1 reference

7 April 2018

author name string

C Qualmann

1

1 reference

7 April 2018

M A Nauck

2

1 reference

7 April 2018

C Orskov

4

1 reference

7 April 2018

W Creutzfeldt

5

1 reference

7 April 2018

publication date

1 March 1995

1 reference

7 April 2018

published in

Acta Diabetologica

1 reference

7 April 2018

volume

32

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

13-16

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/bf00581038

exact match

0 references

cites work

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man

1 reference

12 December 2020

Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

1 reference

12 December 2020

Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas

1 reference

12 December 2020

Glucagon-like peptide-1, a new hormone of the entero-insular axis

1 reference

12 December 2020

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

12 December 2020

Identification and characterization of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung

1 reference

12 December 2020

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

1 reference

12 December 2020

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

12 December 2020

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

12 December 2020

Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate

1 reference

12 December 2020

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

12 December 2020

Gut hormones and diabetes mellitus

1 reference

12 December 2020

GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse

1 reference

12 December 2020

Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).

1 reference

12 December 2020

Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8

1 reference

12 December 2020

Intestinal Factors in the Control of Insulin Secretion

1 reference

12 December 2020

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

12 December 2020

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

12 December 2020

Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans

1 reference

12 December 2020

Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples

1 reference

12 December 2020

Prolonged Maximal Stimulation of Insulin Secretion in Healthy Subjects Does Not Provoke Preferential Release of Proinsulin

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00581038

1 reference

7 April 2018

release_z64u47obgzatrcmcuimmr2imhm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z64u47obgzatrcmcuimmr2imhm

24 November 2022

mapped directly with Wikidata item

1 reference

7 April 2018